510(k) · Cleared
ClearedBD Veritor System for the Rapid Detection of Flu A + B CLIA waived kit
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Becton, Dickinson and Co. · PSZ Devices Detecting Influenza A, B, And C Virus Antigens
Cleared on Oct 27, 2015 as substantially equivalent to K112277 (Becton, Dickinson and Company, 2011) and 3 other predicates after a 27-day review. Its family tree reaches back 10 generations to 1990. 10 later devices descend from it.
- Decided
- Oct 27, 2015
- Review
- 27 days
- Class
- Class II
- Product code
- PSZ
- Recalls
- None
- Predicates
- 4
Its longest line of descent runs back 10 generations to K902609 (1990). 12 ancestors in all. 10 later devices descend from it, 1 citing it directly.
- Root · 10 generations backK902609 Directigen Flu aBd Becton Dickinson Vacutainer Systems Preanalytic · 1990
- 6 generations between
- 3 generations backK132259 BD Veritor System for the Rapid Detection of Flu a+BBecton, Dickinson and Company · 2013
- 2 generations backK132692 BD Veritor System for the Rapid Detection of Flu a+BBecton, Dickinson and Company · 2013
- 1 generation backK151291 BD Veritor (TM) System for the Rapid Detection of Flu A+BBecton, Dickinson and Company · 2015
- This deviceK152870 BD Veritor System for the Rapid Detection of Flu A + B CLIA waived kitBecton, Dickinson and Co. · 2015
- Descendant · cites it directly · 9 of its ownK160161 BD Veritor System for Rapid Detection of Flu A + B CLIA waived kitBecton, Dickinson & CO · 2016
- Descendant · 2 generations on · 5 of its ownK180438 BD Veritor System for Rapid Detection of Flu A + B CLIA waived kitBd · 2018 · Recalled
- Descendant · 2 generations on · 2 of its ownK223016 BD VeritorTM System for Rapid Detection of Flu A+B CLIA-Waived KitBd · 2023
- Descendant · 2 generations on · 2 of its ownK162642 Alere BinaxNOW Influenza A & B Card 2, Alere Reader, Alere BinaxNOW…Alere Scarborough, Inc. · 2017
- Descendant · 3 generations on · 1 of its ownK232434 BD Veritor™ System for Rapid Detection of Flu A+B CLIA Waived KitBd · 2023
Show all 10 generations
- Root · 10 generations backK902609 Directigen Flu aBd Becton Dickinson Vacutainer Systems Preanalytic · 1990
- 9 generations backK981651 AB Flu OiaBiostar, Inc. · 1998
- 8 generations backK023556 Flu Oia a/B Test KitThermo Biostar, Inc. · 2003 · Recalled
- 7 generations backK031899 Quickvue Influenza a+B TestQuidel Corp. · 2003
- 6 generations backK053146 Quickvue Influenza a + B TestQuidel Corp. · 2005
- 5 generations backK092698 Quickvue Influenza a+B TestQuidel Corp. · 2009
- 4 generations backK112277 BD Veritor (TM) System for Rapid Detection of Flu a+BBecton, Dickinson and Company · 2011 · Recalled
- 3 generations backK132259 BD Veritor System for the Rapid Detection of Flu a+BBecton, Dickinson and Company · 2013
- 2 generations backK132692 BD Veritor System for the Rapid Detection of Flu a+BBecton, Dickinson and Company · 2013
- 1 generation backK151291 BD Veritor (TM) System for the Rapid Detection of Flu A+BBecton, Dickinson and Company · 2015
- This deviceK152870 BD Veritor System for the Rapid Detection of Flu A + B CLIA waived kitBecton, Dickinson and Co. · 2015
Showing 5 of 10 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 10 · See all- K160161BD Veritor System for Rapid Detection of Flu A + B CLIA waived kitBecton, Dickinson & CO · 2016 · cites it directly9descendants
- K180438BD Veritor System for Rapid Detection of Flu A + B CLIA waived kitBd · 2018 · 2 generations on5descendants
- K223016BD VeritorTM System for Rapid Detection of Flu A+B CLIA-Waived KitBd · 2023 · 2 generations on2descendants
- K162642Alere BinaxNOW Influenza A & B Card 2, Alere Reader, Alere BinaxNOW Influenza A & B Card…Alere Scarborough, Inc. · 2017 · 2 generations on2descendants
- K232434BD Veritor™ System for Rapid Detection of Flu A+B CLIA Waived KitBd · 2023 · 3 generations on1descendant
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −10 | K902609 | Directigen Flu a | Bd Becton Dickinson Vacutainer Systems Preanalytic | 1990 | — |
| −9 | K981651 | AB Flu Oia | Biostar, Inc. | 1998 | — |
| −8 | K023556 | Flu Oia a/B Test Kit | Thermo Biostar, Inc. | 2003 | 1 |
| −7 | K031899 | Quickvue Influenza a+B Test | Quidel Corp. | 2003 | — |
| −6 | K053146 | Quickvue Influenza a + B Test | Quidel Corp. | 2005 | — |
| −5 | K092698 | Quickvue Influenza a+B Test | Quidel Corp. | 2009 | — |
| −4 | K112277 | BD Veritor (TM) System for Rapid Detection of Flu a+B | Becton, Dickinson and Company | 2011 | 1 |
| −3 | K132259 | BD Veritor System for the Rapid Detection of Flu a+B | Becton, Dickinson and Company | 2013 | — |
| −2 | K132692 | BD Veritor System for the Rapid Detection of Flu a+B | Becton, Dickinson and Company | 2013 | — |
| −1 | K151291 | BD Veritor (TM) System for the Rapid Detection of Flu A+B | Becton, Dickinson and Company | 2015 | — |
| 0 (this device) | K152870 | BD Veritor System for the Rapid Detection of Flu A + B CLIA waived kit | Becton, Dickinson and Co. | 2015 | — |
| +1 | K160161 | BD Veritor System for Rapid Detection of Flu A + B CLIA waived kit | Becton, Dickinson & CO | 2016 | — |
| +2 | K180438 | BD Veritor System for Rapid Detection of Flu A + B CLIA waived kit | Bd | 2018 | 2 |
| +2 | K223016 | BD VeritorTM System for Rapid Detection of Flu A+B CLIA-Waived Kit | Bd | 2023 | — |
| +2 | K162642 | Alere BinaxNOW Influenza A & B Card 2, Alere Reader, Alere BinaxNOW Influenza… | Alere Scarborough, Inc. | 2017 | — |
| +3 | K232434 | BD Veritor™ System for Rapid Detection of Flu A+B CLIA Waived Kit | Bd | 2023 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2016 | 1 | 0 |
| 2017 | 2 | 0 |
| 2018 | 2 | 0 |
| 2020 | 1 | 0 |
| 2023 | 2 | 0 |
| 2025 | 1 | 0 |
| 2026 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in PSZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new PSZ device
- #1 K252283 Nano-Check Influenza A+B Testscore 14.9 · 15 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (4)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K112277 | BD Veritor (TM) System for Rapid Detection of Flu a+BSummary page 4…CFR 866.3330 PREDICATE DEVICES : BD Veritor™ System for Rapid Detection of Flu A+B CLIA waived kit (k112277 ,k132259, k132692, k151291) INTENDED USE : CLIA waived kit The BD Veritor System fo… | 2011 |
| * | K132259 | BD Veritor System for the Rapid Detection of Flu a+BSummary page 4…3330 PREDICATE DEVICES : BD Veritor™ System for Rapid Detection of Flu A+B CLIA waived kit (k112277 ,k132259, k132692, k151291) INTENDED USE : CLIA waived kit The BD Veritor System for Rapid D… | 2013 |
| * | K132692 | BD Veritor System for the Rapid Detection of Flu a+BSummary page 4…DICATE DEVICES : BD Veritor™ System for Rapid Detection of Flu A+B CLIA waived kit (k112277 ,k132259, k132692, k151291) INTENDED USE : CLIA waived kit The BD Veritor System for Rapid Detection… | 2013 |
| * | K151291 | BD Veritor (TM) System for the Rapid Detection of Flu A+BSummary page 4…System for Rapid Detection of Flu A+B CLIA waived kit (k112277 ,k132259, k132692, k151291) INTENDED USE : CLIA waived kit The BD Veritor System for Rapid Detection of Flu A+B CLIA waived assay is a rapid chromatograph… | 2015 |
What descends from it? (10)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K160161 | BD Veritor System for Rapid Detection of Flu A + B CLIA waived kit | 2016 | 9 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 25 years and passes through 6 companies; a new generation was cleared every 2.1 years on median.
- 2 of the 12 ancestors have a recall of any class.
- Of its descendants, K160161 (Becton, Dickinson & CO, 2016) has gone furthest, with 9 descendants of its own.
- 7 other devices also cite its predicate K112277.
How does its category compare?
All PSZ devicesPSZ Devices Detecting Influenza A, B, And C Virus Antigens: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.
FDA decisions per year · PSZ
2in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · PSZ
28in 2018
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · PSZ
1in 2022
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · PSZ
60in 2025
MAUDE reports naming product code PSZ, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 2 | — | 0 | 0 |
| 2008 | 1 | — | 0 | 0 |
| 2009 | 7 | 20 | 0 | 0 |
| 2010 | 5 | 29 | 0 | 0 |
| 2011 | 3 | 80 | 0 | 0 |
| 2012 | 2 | — | 0 | 0 |
| 2013 | 8 | 28 | 0 | 0 |
| 2014 | 1 | — | 0 | 0 |
| 2015 | 4 | 27 | 0 | 0 |
| 2016 | 3 | 29 | 0 | 0 |
| 2017 | 3 | 200 | 0 | 0 |
| 2018 | 5 | 28 | 0 | 1 |
| 2019 | 0 | — | 0 | 1 |
| 2020 | 2 | — | 1 | 5 |
| 2021 | 0 | — | 0 | 42 |
| 2022 | 0 | — | 1 | 10 |
| 2023 | 2 | — | 0 | 12 |
| 2024 | 0 | — | 0 | 16 |
| 2025 | 2 | — | 0 | 60 |
| 2026 | 2 | — | 0 | — |
What is it indicated for?
The BD Veritor System for Rapid Detection of Flu A+B is a rapid chromatographic immunoassay for the direct and qualitative detection of influenza A and B viral nucleoprotein antigens from nasal and nasopharyngeal swabs of symptomatic patients. The BD Veritor System for Rapid Detection of Flu A+B (also referred to as the BD Veritor System and BD Veritor System Flu A+B) is a differentiated test, such that influenza A viral antigens can be distinguished…
Read the full statement (348 words)
The BD Veritor System for Rapid Detection of Flu A+B is a rapid chromatographic immunoassay for the direct and qualitative detection of influenza A and B viral nucleoprotein antigens from nasal and nasopharyngeal swabs of symptomatic patients. The BD Veritor System for Rapid Detection of Flu A+B (also referred to as the BD Veritor System and BD Veritor System Flu A+B) is a differentiated test, such that influenza A viral antigens can be distinguished from influenza B viral antigens from a single processed sample using a single device. The test is to be used as an aid in the diagnosis of influenza A and B viral infections. A negative test is presumptive and it is recommended that these results be confirmed by viral culture or an FDA-cleared influenza A and B molecular assay. Outside the U.S., a negative test is presumptive and it is recommended that these results be confirmed by viral culture or a molecular assay cleared for diagnostic use in the country of use. FDA has not cleared this device for use outside of the U.S. Negative test results do not preclude influenza viral infection and should not be used as the sole basis for treatment or other patient management decisions. The test is not intended to detect influenza C antigens.
Performance characteristics for influenza A and B were established during January through March of 2011 when influenza viruses A/2009 H1N1, A/H3N2, B/Victoria lineage, and B/Yamagata lineage were the predominant influenza viruses in circulation according to the Morbidity and Mortality Weekly Report from the CDC entitled “Update: Influenza Activity—United States, 2010-2011 Season, and Composition of the 2011-2012 Influenza Vaccine.” Performance characteristics may vary against other emerging influenza viruses.
If infection with a novel influenza virus is suspected based on current clinical and epidemiological screening criteria recommended by public health authorities, specimens should be collected with appropriate infection control precautions for novel virulent influenza viruses and sent to the state or local health department for testing. Virus culture should not be attempted in these cases unless a BSL 3+ facility is available to receive and culture specimens.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K152870 · printed Nov 6, 2026
Cite this page
510(k) Report. “K152870: BD Veritor System for the Rapid Detection of Flu A + B CLIA waived kit.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K152870
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026